Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

TitlePharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection
Publication TypeJournal Article
Year of Publication2020
AuthorsPham, H. Thi, M. A. Xiao, M. A. V. Principe, A. Wong, and T. Mespl├Ęde
JournalDrugs in Context
Volume9